Characteristics of two mouse bcr-abl-transformed cell lines. II. Pathological lesions induced in mice

Folia Biologica

Volumn 51, Issue 4, 2005, Pages 93-102

  Jelínek, František ^a,b   Sobotkova E ^a   Vonka, V ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b Veterinary Histopathological laboratory Prague   (Czech Republic)

Author keywords

Bcr abl transformed cells; Implantation; Mice; Pathological lesions

Indexed keywords

BCR ABL PROTEIN; CD11B ANTIGEN; CD3 ANTIGEN; CD79B ANTIGEN; GRANULOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; ANIMAL CELL; ANIMAL TISSUE; APATHY; ARTICLE; AUTOPSY; CELL INFILTRATION; CELL LINE; DEHYDRATION; ENZYME HISTOCHEMISTRY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG HEMORRHAGE; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PARESIS; SPLENOMEGALY; TUMOR CELL;

ANIMALIA;

EID: 24944492181     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Daley, G. Q., Baltimore, D. (1988) Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr-abl protein. Proc. Natl. Acad. Sci. USA 85, 9312-9316.
2. Daley, G. Q., Van Etten, R. A., Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830.
3. Daley, G. Q., Van Etten, R. A., Baltimore, D. (1991) Blast crisis in a murine model of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. 88, 11335-11338.
4. Deng, M., Daley, G. Q. (2001) Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. Blood 97, 3491-3497.
5. Ilaria, R. L., Jr. (2004) Animal models of chronic myeloid leukemia. Hematol. Oncol. Clin. North Amer. 18, 525-543.
6. Jacobs, R. M., Messick, J. B., Valli, V. E. (2002) Tumors of the hemolymphatic system. In: Tumors in Domestic Animals, Fourth Edition, ed. Meuten, D. J., pp. 119-198, Iowa State Press.
7. Konopka, J. B., Witte, O. N. (1985) Activation of the abl oncogene in murine and human leukemias. Biochim. Biophys. Acta 823, 1-17.
8. Li, S., Ilaria, R. L., Milion, R. P., Daley, G. Q., Van Etten, R. A. (1999) The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189, 1399-1412.
9. Lojda, Z., Papoušek, F. (1970) Bases of Histochemical Demonstration of Enzymes. Textbook. Institute for Postgraduate Education of Medical Personnel, Department for Education of Laboratory Technicians, Brno, CZ, 110 pp. (in Czech)
10. McLauglin, J., Cjianese, E., Witte, O. N. (1987) In vitro transformation of immature haemopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 84, 6558-6592.
11. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Qackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., Baltimore, D. (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92, 3780-3792.
12. Sobotková, E., Ludvíková, V., Petráčková, M., Dušková, M., Smetana, K., Jelínek, F., Marinov, I., Vonka, V. (2005) Characteristic of two mouse bcr-abl-transformed cell lines: I. General properties of the cells. Folia Biol. (Praha) 51, 12-18.
13. Valli, V. E., Jacobs, R. M., Parodi, A. L., Vernau, W., Moore, P. F. (2002) Histological Classification of Hematopoietic Tumors of Domestic Animals. Armed Forces Institute of Pathology, American Registry of Pathology and the World Health Organization Center for Worldwide Reference on Comparative Oncology, p. 190, Washington, DC.
14. Van Etten, R. A. (2001) Models of chronic myeloid leukemia. Curr. Oncol. Rep. 3, 228-237.